Aniridia is a devastating ocular disease requiring intensive eye care, social and community support from birth and throughout an individual’s lifetime.

Recent News

© 2019 – University of Cologne – Webdesign by Effect Group Ltd.


Successful meeting with wide participation of researchers, ophthalmologist, patient’s representatives and special interest groups in the 1st COST Action CA18116 MC/WG meeting celebrated last week in Paris. Grant execution updates, working group advancements as well as interesting scientific discussions were brought together in this aniridia-focused session funded by the COST program....